Release Date: 31/10/12 11:36 Summary: Quarterly Cashflow Report Price Sensitive: No Download Document 101.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%